A Refined Approach to Isolate Interneurons for High-Validity Epigenetic Studies in Human Brain Tissue

Epigenetic research has made notable progress in recent years, yet our ability to explore the human brain at a cellular level remains limited. One of the main obstacles has been the difficulty of isolating specific neuronal populations from postmortem tissue—particularly interneurons, which play a c...

ver descrição completa

Detalhes bibliográficos
Autores: Cariaga-Martínez, Ariel, Gutierrez, Kilian Jesús, Regidor, Ignacio, Del Álamo, Marta, Saiz-Ruiz, Jerónimo, Alelú-Paz, Raúl
Formato: artículo
Fecha de publicación:2025
País:España
Recursos:Universidad de Málaga
Repositorio:DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
Idioma:inglés
OAI Identifier:oai:ddfv.ufv.es:10641/6840
Acesso em linha:https://hdl.handle.net/10641/6840
Access Level:acceso abierto
Palavra-chave:brain epigenetics
cortical interneurons
human brain tissue
neuronal isolation
Biotechnology
Structural Biology
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Journal Article
Yes
yes
Descrição
Resumo:Epigenetic research has made notable progress in recent years, yet our ability to explore the human brain at a cellular level remains limited. One of the main obstacles has been the difficulty of isolating specific neuronal populations from postmortem tissue—particularly interneurons, which play a central role in many psychiatric disorders. In this study, we present a practical and reproducible protocol for isolating GAD-positive interneurons from human brain samples. We isolate permeabilized cell-like structures suitable for downstream epigenetic analysis. To ensure specificity, we validated the isolated cells by comparing them with interneurons derived from human iPSCs. This approach allows for high-quality DNA extraction suitable for downstream epigenetic analysis, including methylation-specific PCR. By targeting a well-defined neuronal subtype, our method provides a solid foundation for studying the molecular changes associated with disorders such as schizophrenia and autism. This protocol opens new doors for cell-specific investigations in brain tissue, a step forward in understanding how epigenetic mechanisms contribute to neuropsychiatric pathophysiology.